SHA:688658

3 stories mentioning SHA:688658Updated 41d ago

Every FINWIRES story that references SHA:688658, newest first.

What's the latest news on SHA:688658?

Youcare Pharmaceutical's Unit Gets US FDA's Nod to Trial YKYY033 Injection

Youcare Pharmaceutical's (SHA:688658) unit, Beijing Youcare Kechuang Pharmaceutical Technology, received approval from the U.S. Food and Drug Administration to proceed with the clinical trial of YKYY033 injection, according to a Shanghai bourse filing on Thursday.The drug will be tested as a prevention and treatment for arterial and venous thrombosis.The Chinese pharmaceutical company's shares rose 1% during the afternoon trade.

SHA:688658

Asia48d ago

Youcare Pharmaceutical Receives China Clinical Trial Nod for Nebulized Inhaler

Youcare Pharmaceutical (SHA:688658) obtained clinical trial approval from China's National Medical Products Administration for the YKYY017 nebulized inhaler.The drug is indicated for coronavirus infections, according to a Thursday filing with the Shanghai bourse.

SHA:688658

Asia162d ago

Youcare Pharmaceutical Gets China Clinical Trial Nod for Respiratory Syncytial Virus, Shingles Jabs

China's drug regulator approved the phase 1 clinical trial application for the YKYY025 injection of Youcare Pharmaceutical (SHA:688658) subsidiaries Beijing Yuekang Kechuang Pharmaceutical Technology and Hangzhou Tianlong Pharmaceutical.The vaccine is indicated for the prevention of lower respiratory tract diseases caused by respiratory syncytial virus, according to a Tuesday disclosure to the Shanghai Stock Exchange.The regulator also approved the subsidiaries' YKYY026 vaccine for herpes zoster or shingles, according to a separate filing.

SHA:688658

Track with the FINWIRES app suite

FolioX

Track SHA:688658 in your portfolio

WheelAI

Analyze SHA:688658 options with the wheel strategy

StockInsider

See market sentiment on SHA:688658